Keyphrases
Birth Timing
33%
Breast Cancer
66%
Breast Cancer Cases
16%
Cancer-related
16%
Confidence Interval
16%
During Pregnancy
16%
Epstein-Barr Virus
66%
Epstein-Barr Virus Early Antigen
16%
Epstein-Barr Virus Infections
100%
Epstein-Barr Virus Reactivation
33%
Etiological Agents
16%
High-risk Pregnancy
50%
Immunoglobulin G Antibodies
16%
Immunological Markers
16%
Immunomodulator
16%
Joint Effect
100%
Maternity
16%
Nested Case-control Study
16%
Non-associated
16%
Odds Ratio
33%
Partum
16%
Pregnancy-associated Cancer
100%
Risk Estimation
16%
Seropositivity
16%
Serum Immunoglobulin G
16%
Viral
16%
Virus
16%
Vitamin D
100%
Vitamin D Status
50%
Zebra
16%
Medicine and Dentistry
Breast Cancer
100%
Case-Control Study
11%
Childbirth
11%
Disease
11%
Early Antigen
11%
Epstein Barr Virus
77%
Epstein-Barr Virus Infection
100%
Immediate Early Protein BZLF1
11%
Immunoglobulin G Antibody
11%
Immunomodulating Agent
11%
Obstetrics
11%
Odds Ratio
22%
Virus Reactivation
22%
Vitamin D
100%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Case-Control Study
11%
Disease
11%
Early Antigen
11%
Epstein Barr Virus Infection
100%
Epstein-Barr Virus
77%
Immediate Early Protein BZLF1
11%
Immunoglobulin G Antibody
11%
Immunomodulating Agent
11%
Vitamin D
100%
Immunology and Microbiology
Early Antigen
11%
Epstein Barr Virus
100%
Immediate Early Protein BZLF1
11%
Immunoglobulin Blood Level
11%
Immunoglobulin G Antibody
11%
Immunomodulating Drugs
11%
Monospecific Antibody
11%
Seropositivity
11%
Viral Disease
100%
Virus Reactivation
22%
Vitamin Blood Level
11%